REGENXBIO INC (RGNX) Stock Analyst Ratings
NASDAQ:RGNX - Nasdaq - US75901B1070 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to RGNX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.58. This target is 245.78% above the current price.
RGNX was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RGNX.
In the previous month the buy percentage consensus was at a similar level.
RGNX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-17 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-02-11 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-01-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-10 | Raymond James | Reiterate | Outperform |
| 2024-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-05 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | Goldman Sachs | Initiate | Buy |
| 2024-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-12 | Stifel | Maintains | Buy -> Buy |
| 2024-03-11 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-08 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2024-03-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-06 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | Baird | Maintains | Outperform -> Outperform |
| 2024-02-28 | Wedbush | Reiterate | Neutral -> Neutral |